Rocket Lab
RKLB
$79.68
-5.82%
Rocket Lab Corporation is a vertically integrated space company that designs, manufactures, and operates launch vehicles and spacecraft, providing end-to-end mission services for civil, defense, and commercial markets. It is a leading disruptor in the small satellite launch and space systems sector, positioned as a key alternative to SpaceX with its Electron launch vehicle and expanding Neutron program. The current investor narrative is driven by strategic acquisitions like Mynaric to bolster its space systems portfolio, recent major contract wins, and the broader market sentiment uplift from the SpaceX IPO announcement, all fueling a debate about its path to profitability amidst rapid growth.…
RKLB
Rocket Lab
$79.68
Related headlines
RKLB 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rocket Lab's 12-month outlook, with a consensus price target around $103.58 and implied upside of +30.0% versus the current price.
Average Target
$103.58
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$64 - $104
Analyst target range
Analyst coverage is limited, with only 6 analysts providing estimates, indicating this is still a stock with higher volatility and less efficient price discovery typical of growth-oriented small to mid-caps. The consensus sentiment leans bullish, with recent institutional ratings including actions like Morgan Stanley upgrading to 'Overweight' and firms like Needham and Stifel maintaining 'Buy' ratings, though others like Goldman Sachs and Citizens have 'Neutral' or 'Market Perform' stances. The wide range in revenue estimates for the forward period, from a low of $2.14 billion to a high of $2.94 billion against an average of $2.49 billion, signals high uncertainty and divergent views on the company's growth trajectory and the successful integration of its acquisitions.
RKLB Technical Analysis
The stock is in a sustained, volatile uptrend, evidenced by a staggering 329.58% one-year price change, but is currently trading in a consolidation phase. With a current price of $84.8, it sits approximately 85% of the way up from its 52-week low of $18.21 toward its high of $99.58, indicating it is trading near the upper end of its annual range, which reflects strong momentum but also potential for overextension. Recent momentum shows a significant divergence, with a strong 22.05% gain over the past month sharply contrasting with a -11.94% loss over the past three months, suggesting the stock is recovering from a sharp pullback and attempting to re-establish its longer-term uptrend. The stock's beta of 2.205 indicates it is over 120% more volatile than the broader market, which is critical for risk assessment, with key technical support at the recent March low near $57.38 and major resistance at the 52-week high of $99.58; a breakout above resistance would signal a resumption of the powerful uptrend, while a breakdown below $57 could indicate a deeper correction.
Beta
2.21
2.21x market volatility
Max Drawdown
-43.0%
Largest decline past year
52-Week Range
$20-$100
Price range past year
Annual Return
+264.2%
Cumulative gain past year
| Period | RKLB Return | S&P 500 |
|---|---|---|
| 1m | +9.3% | +8.7% |
| 3m | -10.4% | +3.6% |
| 6m | +23.4% | +5.4% |
| 1y | +264.2% | +30.6% |
| ytd | +4.9% | +4.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RKLB Fundamental Analysis
Revenue growth is robust and accelerating, with Q4 2025 revenue of $179.65 million representing a 35.7% year-over-year increase, and the sequential trend from Q1 ($122.57M) to Q4 shows consistent quarterly growth. The company remains unprofitable, with a Q4 net income of -$52.92 million, but there is a notable improvement in net margin from -49.5% in Q1 to -29.5% in Q4, while gross margin expanded to 37.98% in Q4 from 28.76% in Q1, indicating progress on the path to profitability. The balance sheet shows a strong liquidity position with a current ratio of 4.08 and a low debt-to-equity ratio of 0.147, but cash flow remains a critical watchpoint as the company reported negative free cash flow of -$114.19 million for Q4 and a trailing twelve-month FCF of -$321.81 million, indicating it is still heavily reliant on external financing to fund its growth and capital expenditures.
Quarterly Revenue
$179652000.0B
2025-12
Revenue YoY Growth
+0.35%
YoY Comparison
Gross Margin
+0.37%
Latest Quarter
Free Cash Flow
$-321806000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RKLB Overvalued?
Given the company's negative net income and EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is an extremely high 61.51x, while the forward-looking metric, EV-to-Sales, stands at 76.95x, indicating the market is pricing in significant future revenue growth and margin expansion. Compared to typical industrials or aerospace & defense peers, this multiple represents a massive premium, which the market is assigning based on Rocket Lab's hyper-growth profile and first-mover status in the small launch segment. Historically, the stock's own PS ratio has fluctuated wildly, from a low around 21.1x in mid-2024 to a recent high of 222.3x at the end of 2025; the current 61.5x, while down from that peak, remains elevated versus its own history, suggesting the market's expectations, though tempered, are still optimistic regarding its long-term market capture and profitability timeline.
PE
-186.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -347x~434x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-234.4x
Enterprise Value Multiple
